Yili Chuanning Biotechnology Co.,Ltd. (SHE:301301)
11.26
+0.54 (5.04%)
At close: Mar 27, 2026
SHE:301301 Market Cap
SHE:301301 has a market cap or net worth of 25.11 billion as of March 27, 2026. Its market cap has decreased by -11.85% in one year.
Market Cap
25.11B
Enterprise Value
25.62B
Revenue
4.74B
Ranking
n/a
PE Ratio
26.95
Stock Price
11.26
Market Cap Chart
Since December 27, 2022, SHE:301301's market cap has increased from 22.34B to 25.11B, an increase of 12.41%. That is a compound annual growth rate of 3.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 25.11B | 11.05% |
| Dec 31, 2025 | 22.61B | -14.39% |
| Dec 31, 2024 | 26.41B | 41.47% |
| Dec 29, 2023 | 18.67B | -6.15% |
| Dec 30, 2022 | 19.89B | -10.95% |
| Dec 27, 2022 | 22.34B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chongqing Zhifei Biological Products | 35.38B |
| Asymchem Laboratories (Tianjin) | 33.99B |
| Hebei Changshan Biochemical Pharmaceutical | 33.74B |
| Beijing Tiantan Biological Products | 29.58B |
| Xiamen Amoytop Biotech | 27.06B |
| Hualan Biological Engineering | 26.35B |
| Suzhou Zelgen Biopharmaceuticals | 24.71B |
| BrightGene Bio-Medical Technology | 19.65B |